W96 EFFICACY OF 4/7 DAYS MAINTENANCE ART STRATEGY: ANRS-170 QUATUOR TRIAL
Intermittent treatment could improve the convenience, tolerability and cost of ART. We have previously demonstrated in the QUATUOR trial the non-inferiority of maintenance 4 days-a-week (4/7days) versus 7/7days in patients (pts) under triple therapy with either PI, NNRTI, or InSTI based regimen: 95.6% vs 97.2% treatment success at W48. ClinicalTrials.gov:NCT03256422. We report here the W96…